Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2022-11-06 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
关于2022年限制性股票与股票期权激励计划股票期权预留授予登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the registration of reserved stock options under the company's 2022 restricted stock and stock option incentive plan. It details the approval process, allocation, conditions, and impact of the stock option plan. The content focuses on the stock option incentive plan, its registration, and related corporate governance matters. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement about stock option grants and related corporate actions. This fits best under Capital/Financing Update (CAP), as it relates to stock option grants and equity incentives, which are financing and capital structure related activities.
2022-11-06 Chinese
关于向特定对象发行可转换公司债券解除锁定的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from Changchun High-tech Industry (Group) Co., Ltd. regarding the unlocking of convertible bonds issued to a specific party. It details the bond issuance, lock-up periods, performance commitments, and the unlocking schedule. The content focuses on a specific capital market event related to convertible bonds, including issuance details, lock-up release, and compliance with commitments. There are no financial statements, earnings data, or management discussion typical of financial reports. The document is an announcement about a capital market transaction and related unlocking event, fitting the category of Capital/Financing Update (CAP). The document length is 2591 characters, which is consistent with an announcement rather than a full report.
2022-11-02 Chinese
关于发行股份及可转换债券购买资产之新增股份部分解除限售的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on certain shares previously issued as part of a transaction involving issuance of shares and convertible bonds to purchase assets. It includes specifics about the number of shares being unlocked, the shareholders involved, the lock-up periods, performance commitments, and compliance with regulatory approvals. The document references approvals from the China Securities Regulatory Commission and details about shareholding changes and commitments by shareholders. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about share unlocking and related shareholder commitments. This fits the category of a Regulatory Filing (RNS) as it is a formal regulatory announcement about share restrictions being lifted and related compliance, not a report or financial statement itself.
2022-10-31 Chinese
中信建投证券、中天国富证券关于长春高新发行股份及可转换债券购买资产并募集配套资金暨关联交易之部分限售股份上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the unlocking and listing of restricted shares related to a transaction involving issuance of shares and convertible bonds for asset purchase and fundraising by Changchun High-tech Industry (Group) Co., Ltd. It references regulatory approvals, specific share lock-up periods, performance commitments, audit reports on performance fulfillment, and the final unlocking and listing of shares. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal verification opinion by financial advisors on the compliance and legitimacy of the share unlocking and listing process, which fits the category of Audit Report / Information (AR) as it involves audit opinions and regulatory compliance verification related to a specific transaction and share listing event. The document length and content confirm it is not a brief announcement or a proxy statement, but a substantive audit-related report. FY 2022
2022-10-31 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 年第三季度报告" which translates to "2022 Third Quarter Report". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary on financial performance for the third quarter of 2022. The document explicitly states it is a quarterly report and is unaudited. The length and content indicate it is a comprehensive interim financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-10-27 Chinese
监事会关于2022年限制性股票与股票期权激励计划预留授予激励对象名单的公示情况说明及核查意见
Regulatory Filings Classification · 95% confidence The document is a public announcement by the supervisory board regarding the verification and disclosure of the list of reserved grant recipients under the 2022 restricted stock and stock option incentive plan. It includes details about the internal review, public disclosure, and confirmation of the eligibility of the incentive recipients. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement related to the company's stock incentive plan and internal governance but does not fit into categories like Annual Report, Interim Report, or Remuneration Information. It is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure about the incentive plan and verification results without being a full report or financial document.
2022-10-10 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.